<i>C. sinensis</i> ESPs facilitated ferroptosis in AML12 cells. حسب Haoyang Zhang (1706815)

Inhibition of ferroptosis alleviated cell viability induced by <i>C. sinensis</i> ESPs. حسب Haoyang Zhang (1706815)

Box-whisker plots of the relative abundances (%) of coccolithophore species characteristic for the “pseudo-stadial” (PS; 1854.6–1852.8 cm), the interstadial before the YTT eruption... حسب Jose Dominick Guballa (19739909)

Recognition of <i>F. novicida</i> strains by the mitochondria and Golgi complex in THP-1 cells. حسب Dhandy Koesoemo Wardhana (21956781)

Overexpression of miR-184 disrupts the blood-brain barrier and larval locomotion. حسب Sravya Paluri (5475260)

Recognition of <i>F. novicida</i> strains by lysophagosomes and lysosomes in HeLa–FcγRII cells. حسب Dhandy Koesoemo Wardhana (21956781)

Inhibition of ferroptosis mitigated liver injury caused by <i>C. sinensis</i> infection. حسب Haoyang Zhang (1706815)

Fer-1 alleviated liver lesions caused by <i>C. sinensis.</i> حسب Haoyang Zhang (1706815)

Liver ferroptosis caused by <i>C. sinensis</i> infection in mice حسب Haoyang Zhang (1706815)

Inhibition of ferroptosis alleviated the expression of hepatic حسب Haoyang Zhang (1706815)

Microbial metabolic potentials categorized according to KEGG (A) level 1 and (B) level 2, representing control vs. stroke groups. حسب Duangnapa Roongpiboonsopit (12829198)

Inhibition of ferroptosis alleviated liver fibrosis caused by <i>C. sinensis.</i> حسب Haoyang Zhang (1706815)

Recognition of <i>F. novicida</i> strains by the mitochondria and Golgi complex in HeLa–FcγRII cells. حسب Dhandy Koesoemo Wardhana (21956781)

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"